Biocryst Pharmaceuticals Cash Flow Statement (2010-2026) | BCRX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-43.20M-58.80M-17.78M-74.20M-58.86M-42.52M-71.54M-53.33M-75.33M-36.15M-61.73M-35.38M-12.67M-14.03M-26.80M0.03M5.08M12.90M245.84M-721.81M
Depreciation and Depletion (Quarter)
0.33M0.46M
Share-based Compensation (Quarter)
7.63M13.03M8.50M9.60M9.87M9.95M15.28M14.01M12.84M12.28M16.49M13.65M13.17M17.25M21.34M21.37M21.30M18.60M23.79M16.03M
Gains from Investment Securities (Quarter)
0.10M1.11M0.90M0.06M2.35M1.84M-4.19M7.54M0.00M1.05M0.51M7.28M1.43M
Asset Writedowns and Impairment (Quarter)
0.24M0.00M-0.00M1.31M0.00M1.36M-0.01M0.21M0.82M0.03M-0.07M0.07M
Non-cash Items (Quarter)
Cash from Operations (Quarter)
-25.41M-23.28M-32.46M-77.80M-27.76M-32.44M-23.85M-47.51M-18.81M-19.90M-8.92M-53.68M-1.37M8.24M-5.21M-27.52M41.30M41.62M291.96M-61.79M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.02M0.00M-0.04M0.03M-0.12M-0.73M-0.96M-1.39M-2.83M-2.60M-3.45M-3.18M-3.49M-2.04M-2.76M-1.38M-1.15M-0.71M-1.09M0.60M
Amortization of Deferred Charges (Quarter)
3.91M5.41M
Depreciation & Amortization (CF) (Quarter)
0.20M0.23M0.17M0.32M0.34M0.39M0.40M0.41M0.41M0.42M0.42M0.31M0.32M0.31M0.31M0.33M0.33M0.34M0.39M0.46M
Change in Working Capital
Change in Receivables (Quarter)
18.71M-1.40M3.24M7.05M5.29M1.48M7.64M-2.02M8.99M-3.84M2.97M3.84M8.25M3.32M7.30M13.99M7.31M0.02M15.49M0.47M
Change in Inventory (Quarter)
4.74M3.82M2.14M0.35M7.24M3.67M1.16M-0.13M-0.90M3.39M-0.91M1.22M-0.74M1.52M2.16M0.87M-1.44M1.69M0.52M4.85M
Change in Account Payables (Quarter)
10.12M13.95M22.72M-22.91M14.45M-19.18M5.28M-27.23M-0.19M-9.26M49.21M-44.57M20.54M18.41M20.40M-32.59M30.46M24.58M35.36M-60.40M
Change in Accured Expenses (Quarter)
1.67M0.34M0.28M6.34M-6.34M
Other Working Capital Changes (Quarter)
-9.45M0.05M0.83M2.32M-1.27M0.08M1.45M-0.04M0.57M-1.35M-0.42M-1.11M-1.75M1.47M1.39M-0.03M5.92M1.94M-0.75M
Investing Activities
Capital Expenditures (Quarter)
0.81M0.36M1.11M0.41M0.24M0.17M0.53M0.16M0.47M0.99M-1.61M0.23M-0.23M0.45M0.68M1.07M0.60M-1.06M0.61M
Acquisitions (Quarter)
489.48M
Change in Acquisitions & Divestments (Quarter)
5.32M8.11M4.00M35.66M77.74M41.69M66.33M148.00M129.07M117.00M110.00M35.48M58.00M76.00M58.65M73.00M49.00M221.24M
Cash from Investing Activities (Quarter)
4.50M7.75M-11.12M-38.47M-97.44M-69.54M77.22M-107.11M-19.04M23.12M-28.47M28.76M-2.45M8.49M17.80M27.09M29.13M13.57M-83.49M-268.65M
Financing Activities
Other financing activities (Quarter)
0.26M4.95M
Cash from Financing Activities (Quarter)
4.57M4.78M347.42M7.36M0.15M76.33M4.20M5.08M29.36M1.23M-3.17M-1.05M-1.97M1.27M-4.02M0.53M-73.69M-58.81M-217.96M412.55M
Additional items
Exchange Rate Effect (Quarter)
0.09M-0.02M0.00M0.04M0.21M-0.01M0.33M-0.10M-0.32M0.25M0.52M-0.34M-0.14M0.85M-1.30M0.45M1.36M-0.47M-0.07M-0.07M
Change in Cash (Quarter)
-16.25M-10.77M303.84M-108.88M-124.84M-25.68M57.90M-149.64M-8.81M4.70M-40.04M-26.32M-5.93M18.86M7.26M0.56M-1.90M-4.09M-9.56M82.04M
Free Cash Flow (Quarter)
-26.22M-23.64M-33.57M-78.21M-28.00M-32.62M-24.38M-47.67M-19.28M-20.88M-7.30M-53.92M-1.13M7.80M-5.89M-27.52M40.23M41.03M293.02M-62.40M
Net Cash Flow (Quarter)
-16.33M-10.75M303.84M-108.92M-125.05M-25.66M57.56M-149.54M-8.49M4.45M-40.56M-25.98M-5.78M18.01M8.56M0.11M-3.26M-3.62M-9.49M82.11M